Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein

English version České info

Many viruses alter expression of proteins on the surface of infected cells including molecules important for immune recognition, such as the major histocompatibility complex (MHC) class I and II molecules. Virus-induced downregulation of surface proteins has been observed to occur by a variety of mechanisms including impaired transcription, blocks to synthesis, and increased turnover. Viral infection or transient expression of the Ebola virus (EBOV) glycoprotein (GP) was previously shown to result in loss of staining of various host cell surface proteins including MHC1 and β1 integrin; however, the mechanism responsible for this effect has not been delineated. In the present study we demonstrate that EBOV GP does not decrease surface levels of β1 integrin or MHC1, but rather impedes recognition by steric occlusion of these proteins on the cell surface. Furthermore, steric occlusion also occurs for epitopes on the EBOV glycoprotein itself. The occluded epitopes in host proteins and EBOV GP can be revealed by removal of the surface subunit of GP or by removal of surface N- and O- linked glycans, resulting in increased surface staining by flow cytometry. Importantly, expression of EBOV GP impairs CD8 T-cell recognition of MHC1 on antigen presenting cells. Glycan-mediated steric shielding of host cell surface proteins by EBOV GP represents a novel mechanism for a virus to affect host cell function, thereby escaping immune detection.

Vyšlo v časopise: Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein. PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001098
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001098

Souhrn

Zdroje

1. SanchezA

KhanAS

ZakiSR

NabelGJ

KsiazekTG

2001 Filoviridae: Marburg and Eboila Viruses.

KnipeDM

HowleyPM

GriggenDE

LambRA

MartinMA

Fields Virology Lippincott, Williams & Wilkins 1279 1304

2. MahantyS

BrayM

2004 Pathogenesis of filoviral haemorrhagic fevers. The Lancet Infectious Diseases 4 487 498

3. Alazard-DanyN

VolchkovaV

ReynardO

CarbonnelleC

DolnikO

2006 Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. J Gen Virol 87 1247 1257

4. SanchezA

TrappierSG

MahyBW

PetersCJ

NicholST

1996 The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proceedings of the National Academy of Sciences of the United States of America 93 3602 3607

5. VolchkovaVA

FeldmannH

KlenkHD

VolchkovVE

1998 The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology 250 408 414

6. VolchkovVE

FeldmannH

VolchkovaVA

KlenkHD

1998 Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A 95 5762 5767

7. JeffersSA

SandersDA

SanchezA

2002 Covalent modifications of the ebola virus glycoprotein. J Virol 76 12463 12472

8. YangZY

DuckersHJ

SullivanNJ

SanchezA

NabelEG

2000 Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 6 886 889

9. ChanSY

MaMC

GoldsmithMA

2000 Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Gen Virol 81 2155 2159

10. TakadaA

WatanabeS

ItoH

OkazakiK

KidaH

2000 Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278 20 26

11. VolchkovVE

VolchkovaVA

MuhlbergerE

KolesnikovaLV

WeikM

2001 Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 291 1965 1969

12. SimmonsG

Wool-LewisRJ

BaribaudF

NetterRC

BatesP

2002 Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 76 2518 2528

13. RayRB

BasuA

SteeleR

BeyeneA

McHowatJ

2004 Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells. Virology 321 181 188

14. SullivanNJ

PetersonM

YangZY

KongWP

DuckersH

2005 Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. J Virol 79 547 553

15. FrancicaJR

MatukonisMK

BatesP

2009 Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein. Virology 383 237 247

16. ZampieriCA

FortinJF

NolanGP

NabelGJ

2007 The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. J Virol 81 1230 1240

17. BavariS

BosioCM

WiegandE

RuthelG

WillAB

2002 Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195 593 602

18. LeeJE

FuscoML

HessellAJ

OswaldWB

BurtonDR

2008 Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454 177 182

19. JentoftN

1990 Why are proteins O-glycosylated? Trends Biochem Sci 15 291 294

20. Wool-LewisRJ

BatesP

1999 Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. J Virol 73 1419 1426

21. NeumannG

FeldmannH

WatanabeS

LukashevichI

KawaokaY

2002 Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol 76 406 410

22. DolnikO

VolchkovaV

GartenW

CarbonnelleC

BeckerS

2004 Ectodomain shedding of the glycoprotein GP of Ebola virus. Embo J 23 2175 2184

23. KuanSF

ByrdJC

BasbaumC

KimYS

1989 Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J Biol Chem 264 19271 19277

24. HuangJ

ByrdJC

YoonWH

KimYS

1992 Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells. Oncol Res 4 507 515

25. HuetG

Hennebicq-ReigS

de BolosC

UlloaF

LesuffleurT

1998 GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells. J Cell Biol 141 1311 1322

26. BettsMR

NasonMC

WestSM

De RosaSC

MiguelesSA

2006 HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107 4781 4789

27. ReynardO

BorowiakM

VolchkovaVA

DelpeutS

MateoM

2009 Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J Virol 83 9596 9601

28. WilleyRL

MaldarelliF

MartinMA

StrebelK

1992 Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol 66 7193 7200

29. Schneider-SchauliesJ

SchnorrJJ

BrinckmannU

DunsterLM

BaczkoK

1995 Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci U S A 92 3943 3947

30. SchwartzO

MarechalV

Le GallS

LemonnierF

HeardJM

1996 Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2 338 342

31. AnderssonM

PaaboS

NilssonT

PetersonPA

1985 Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43 215 222

32. IshidoS

WangC

LeeBS

CohenGB

JungJU

2000 Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74 5300 5309

33. WenC

HeX

MaH

HouN

WeiC

2008 Hepatitis C virus infection downregulates the ligands of the activating receptor NKG2D. Cell Mol Immunol 5 475 478

34. ThomasM

BonameJM

FieldS

NejentsevS

SalioM

2008 Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc Natl Acad Sci U S A 105 1656 1661

35. HewittEW

2003 The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110 163 169

36. BeckM

StrandMR

2005 Glc1.8 from Microplitis demolitor bracovirus induces a loss of adhesion and phagocytosis in insect high five and S2 cells. J Virol 79 1861 1870

37. WesselingJ

van der ValkSW

VosHL

SonnenbergA

HilkensJ

1995 Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129 255 265

38. KomatsuM

YeeL

CarrawayKL

1999 Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells. Cancer Res 59 2229 2236

39. PinoV

RamsauerVP

SalasP

Carothers CarrawayCA

CarrawayKL

2006 Membrane mucin Muc4 induces density-dependent changes in ERK activation in mammary epithelial and tumor cells: role in reversal of contact inhibition. J Biol Chem 281 29411 29420

40. HollingsworthMA

SwansonBJ

2004 Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4 45 60

41. WesselingJ

van der ValkSW

HilkensJ

1996 A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 7 565 577

42. FukudaM

2002 Roles of mucin-type O-glycans in cell adhesion. Biochim Biophys Acta 1573 394 405

43. WeiX

DeckerJM

WangS

HuiH

KappesJC

2003 Antibody neutralization and escape by HIV-1. Nature 422 307 312

44. OswaldWB

GeisbertTW

DavisKJ

GeisbertJB

SullivanNJ

2007 Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog 3 e9

45. MaruyamaT

RodriguezLL

JahrlingPB

SanchezA

KhanAS

1999 Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol 73 6024 6030

46. McGuckinMA

WalshMD

HohnBG

WardBG

WrightRG

1995 Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol 26 432 439

47. SherblomAP

MoodyCE

1986 Cell surface sialomucin and resistance to natural cell-mediated cytotoxicity of rat mammary tumor ascites cells. Cancer Res 46 4543 4546

48. BertozziCC

ChangCY

JairajS

ShanX

HuangJ

2006 Multiple initial culture conditions enhance the establishment of cell lines from primary ovarian cancer specimens. In Vitro Cell Dev Biol Anim 42 58 62

49. SuhoskiMM

GolovinaTN

AquiNA

TaiVC

Varela-RohenaA

2007 Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther 15 981 988

50. ParryRV

RumbleyCA

VandenbergheLH

JuneCH

RileyJL

2003 CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. J Immunol 171 166 174

51. Varela-RohenaA

MolloyPE

DunnSM

LiY

SuhoskiMM

2008 Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med 14 1390 1395

52. LinG

SimmonsG

PohlmannS

BaribaudF

NiH

2003 Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 77 1337 1346